糖化血红蛋白与大动脉粥样硬化性缺血性卒中患者预后的关系研究

摘要/Abstract

摘要：

目的探讨急性缺血性卒中患者入院时糖化血红蛋白与不良心脑血管预后及神经功能预后的关系。方法入选2010年5月至2011年8月首都医科大学附属北京天坛医院脑血管病中心急性缺血性卒中住院患者373例，所有患者均为TOAST分型大动脉粥样硬化型。记录患者的基线资料，按照入院时患者糖化血红蛋白≥7%或＜7%进行分组并随访。终点事件包括卒中复发、心脑血管事件和心脑血管死亡、随访一年的神经功能恢复情况[改良Rankin量表（modified Rankin Scale，mRS）]。结果共300例患者资料纳入分析，高糖化血红蛋白组83例，低糖化血红蛋白组217例。随访（18.9±5.0）个月。高糖化血红蛋白组糖尿病发病率、1年的mRS评分、心脑血管事件均显著高于低糖化血红蛋白组（P＜0.01），Kaplan-Meier生存分析显示高糖化血红蛋白组患者无心脑血管事件的生存明显低于低糖化血红蛋白组（P＜0.001）。Cox回归发现糖化血红蛋白（HR 1.252，95%CI 1.061～1.477， P =0.008）和既往卒中史（HR 2.630，95%CI 1.365～4.970，P =0.004）是卒中患者心脑血管预后不良的预测因素。Logistic回归分析显示缺血性卒中患者随访一年时神经功能恢复不良的独立危险因素有高龄（OR 1.069，95%CI 1.037～1.101，P＜0.001）、既往有卒中史（OR 4.087，95%CI 2.051～8.144，P＜0.001）、高糖化血红蛋白（OR 1.208，95%CI 1.002～1.455，P =0.047）和入院美国国立卫生研究院卒中量表 (National Institutes of Health Stroke Scale，NIHSS）评分（OR 1.320，95%CI 1.217～1.431，P＜0.001）。结论入院时糖化血红蛋白升高是大动脉粥样硬化性急性缺血性卒中患者一年不良心脑血管预后和不良功能预后的预测因素。

文章导读： 本研究显示入院时的高糖化血红蛋白是大动脉粥样硬化性缺血性卒中患者不良心脑血管预后和不良功能预后的预测因素。

关键词: 卒中; 缺血性; 糖化血红蛋白; 预后

Abstract:

Objective To investigate the association between hemoglobin A1c (HbA1c) and cardiovascular and functional outcome in patients with acute ischemic stroke. Methods A total of 373 inpatients with acute ischemic stroke were recruited and followed up at Cerebrovascular Center of Beijing Tiantan Hospital between May 2010 and August 2011. All patients were diagnosed as TOAST Aorta Atherosclerotic type. The baseline data were recorded. The patients were divided into different groups with the benchmark of HbA1c ≥7% or <7% and were followed up. The endpoint events included stroke recurrence, vascular events, cardiovascular death, and functional status (modified Rankin Scale, mRS) at one year. Results The data of 300 patients were included in the final analysis. The patients were divided into the two groups according to ≥7% or <7%: higher HbA1c group (83 patients) and lower HbA1c group (217 patients). The patients were followed up for 18.9±5.0 months. The patients in higher HbA1c group showed a higher prevalence of diabetes mellitus and cardiovascular events, higher mRS at one year than those in lower HbA1c group (P <0.01). Kaplan-Meier analysis found that the cardiovascular events-free survival was lower in higher HbA1c group than that in lower HbA1c group (P <0.001). Cox regression found HbA1c (HR 1.252, 95%CI 1.061~1.477, P =0.008) andprevious stroke (HR 2.630, 95%CI 1.365~4.970, P =0.004) were the predictive factors for poor cardiovascular outcome in stroke patients. Logistic regression found that age (OR 1.069, 95%CI 1.037~1.101, P <0.001), previous stroke (OR 4.087, 95%CI 2.051~8.144, P <0.001), HbA1c (OR 1.208, 95%CI 1.002~1.455, P =0.047) and National Institutes of Health Stroke Scale (NIHSS) score on admission (OR 1.320, 95%CI 1.217~1.431, P <0.001) were the risk factors for functional status at one year. Conclusion Our study suggests that the HbA1c on admission is an independent significant predictor for poor cardiovascular outcome and functional outcome in patients with aorta atherosclerotic ischemic stroke.

Key words: Stroke, Ischemic; Hemoglobin A1c; Outcome

田俊萍，王鸿，王红霞，赵性泉，陈步星. 糖化血红蛋白与大动脉粥样硬化性缺血性卒中患者预后的关系研究[J]. 中国卒中杂志, 2016, 11(01): 28-33.

TIAN Jun-Ping, WANG Hong, WANG Hong-Xia, et al.. Association between Hemoglobin A1c and Outcome in Patients with Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2016, 11(01): 28-33.

参考文献

1 Yeap BB, McCaul KA, Flicker L, et al. Diabetes,

myocardial infarction and stroke are distinct and

durat ion-dependent predictors of subsequent

cardiovascular events and all-cause mortality in older

men[J]. J Clin Endocrinol Metab, 2015, 100:1038-1047.

2 Goldstein LB, Adams R, Becker K, et al. Primary

prevention of ischemic st roke:A statement for

healthcare professionals from the Stroke Council ofthe American Heart Association[J]. Circulation, 2001,

103:163-182.

3 Sun Y, Toh MP. Impact of diabetes mellitus (DM)

on the health-care utilization and clinical outcomes

of patients with stroke in Singapore[J]. Value Health,

2009, Suppl 3:S101-S105.

4 Jia Q, Zhao X, Wang C, et al. Diabetes and poor

outcomes within 6 months after acute ischemic

stroke:the China National Stroke Registry[J]. Stroke,

2011, 42:2758-2762.

5 Kaarisalo MM, Räihä I, Sivenius J, et al. Diabetes

worsens the outcome of acute ischemic stroke[J].

Diabetes Res Clin Pract, 2005, 69:293-298.

6 Capes SE, Hunt D, Malmberg K, et al. St ress

hyperglycemia and prognosis of stroke in nondiabetic

and diabetic patients:a systematic overview[J]. Stroke,

2001, 32:2426-2432.

7 Hjalmarsson C, Manhem K, Bokemark L, et al. The

role of prestroke glycemic control on severity and

outcome of acute ischemic stroke[J]. Stroke Res Treat,

2014:694569, http://dx.doi.org/10.1155/2014/694569.

8 Kamouchi M, Matsuki T, Hata J, et al. Prestroke

glycemic control is associated with the functional

outcome in acute ischemic stroke:the Fukuoka Stroke

Registry[J]. Stroke, 2011, 42:2788-2794.

9 Wu S, Shi Y, Wang C, et al. Glycated hemoglobin

independently predicts stroke recurrence within one

year after acute first-ever non-cardioembolic strokes

onset in a Chinese cohort study[J]. PLoS One, 2013,

8:e80690.

10 Sakurai M, Saitoh S, Miura K, et al. HbA1c and the

risks for all-cause and cardiovascular mortality in the

general Japanese population:NIPPON DATA90[J].

Diabetes Care, 2013, 36:3759-3765.

11 Wu S, Wang C, Jia Q, et al. HbA1c is associated with

increased all-cause mortality in the first year after acute

ischemic stroke[J]. Neurol Res, 2014, 36:444-452.

12 Li H, Kang Z, Qiu W, et al. Hemoglobin A1C is

independently associated with severity and prognosis of

brainstem infarctions[J]. J Neurol Sci, 2012, 317:87-91.

13 Eme rgi ng Ri sk Fa c t o r s Col labo r a t ion, Di

Angelantonio E, Gao P, et al. Glycated hemoglobin

measurement and prediction of cardiovascular

disease[J]. JAMA, 2014, 311:1225-1233.

14 Birkenhäger-Gillesse EG, den Elzen WP, Achterberg

WP, et al. Associat ion between glycosylatedhemoglobin and cardiovascular events and mortality

in older adults without diabetes mellitus in the general

population:The Leiden 85-Plus Study[J]. J Am Geriatr

Soc, 2015, 63:1059-1066.

15 Bejan-Angoulvant T, Cornu C, Archambault P, et al.

Is HbA1c a valid surrogate for macrovascular and

microvascular complications in type 2 diabetes?[J].

Diabetes Metab, 2015, 41:195-201.

16 Cao W, Ling Y, Wu F, et al. Higher fast ing

glucose next day after intravenous thrombolysis is

independently associated with poor outcome in acute

ischemic stroke[J]. J Stroke Cerebrovasc Dis, 2015,

24:100-103.

17 中华医学会神经病学分会脑血管病学组急性缺血性

脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治

指南2010[J]. 中华神经科杂志, 2010, 43:146-153.

18 Wang Y, Xu J, Zhao X, et al. Association of hypertension

with stroke recurrence depends on ischemic stroke

subtype[J]. Stroke, 2013, 44:1232-1237.

19 Cruz-Herranz A, Fuentes B, Martínez-Sánchez P, et

al. Is diabetes an independent risk factor for in-hospital

complications after a stroke?[J]. J Diabetes, 2014,

30.[Epub ahead of print].

20 刘力生, 王文, 姚崇华. 中国高血压防治指南(2009年

基层版)[J]. 中华高血压杂志, 2010, 18:11-30.

21 中华医学会糖尿病学分会. 中国2型糖尿病防治指南

(2013年版)[J]. 中华糖尿病杂志, 2014, 6:447-498.

22 Montalescot G, SechtemU, Achenbach S, et al. 2013

ESC guidelines on the management of stable coronary

artery disease:the Task Force on the management of

stable coronary artery disease of the European Society

of Cardiology[J]. Eur Heart J, 2013, 34:2949-3003.

23 中国成人血脂异常防治指南制订联合委员会. 中国

成人血脂异常防治指南[J]. 中华心血管病杂志, 2007,

5:390-419.

24 Coull AJ, Rothwell PM. Underestimation of the early

risk of recurrent stroke:evidence of the need for a

standard definition[J]. Stroke, 2004, 35:1925-1929.

25 Rocco A, Heuschmann PU, Schellinger PD, et al.

Glycosylated hemoglobin A1 predicts r isk for

symptomatic hemorrhage after thrombolysis for acute

stroke[J]. Stroke, 2013, 44:2134-2138.

26 Garg R, Chaudhur i A, Munschauer F, e t a l .

Hyperglycemia, insulin, and acute ischemic stroke:A

mechanistic justification for a trial of insulin infusion

therapy[J]. Stroke, 2006, 37:267-273.

[1]	鲁燕, 杨保荣, 黄向萍, 杨冠桂, 陈圣文, 李建荣, 曾小明. 县级医院急性缺血性卒中超时间窗经MRI筛选溶栓的病例对照研究 [J]. 中国卒中杂志, 2022, 17(12): 1321-1326.
[2]	楚悦琪, 周凯云, 王田燕, 王炯彬, 李真. 卒中后吞咽障碍应用耳穴压豆治疗效果的meta分析 [J]. 中国卒中杂志, 2022, 17(12): 1327-1334.
[3]	王恺闻, 卢宝全, 吴秀玲, 马佳丽. 基于MRA评估基底动脉闭塞预后评分预测非重症基底动脉闭塞患者预后效能的研究 [J]. 中国卒中杂志, 2022, 17(12): 1335-1342.
[4]	周甜甜, 苏文杰, 连松勇, 林友聪. 丰富环境对卒中后血管性痴呆患者认知功能的影响 [J]. 中国卒中杂志, 2022, 17(12): 1343-1349.
[5]	吴娱倩, 张玉梅, 范小伟, 王安心, 逄文斌. 运动想象-动觉治疗对缺血性卒中患者手功能康复效果的研究[J]. 中国卒中杂志, 2022, 17(12): 1366-1371.
[6]	蒋林, 李靖. 基于知识图谱分析人工智能用于卒中研究的现状及趋势 [J]. 中国卒中杂志, 2022, 17(12): 1372-1380.
[7]	梁潇, 钱海兵. 水通道蛋白4与卒中后认知障碍的关系研究进展[J]. 中国卒中杂志, 2022, 17(12): 1385-1390.
[8]	吴晓莉, 刘丽旭. 肥胖对卒中预后的影响[J]. 中国卒中杂志, 2022, 17(12): 1391-1395.
[9]	伊珞, 周宏宇, 仇鑫, 李子孝, 王拥军. 动脉粥样硬化性疾病的DNA甲基化改变[J]. 中国卒中杂志, 2022, 17(11): 1163-1170.
[10]	王誉博, 李子孝, 王拥军. 表观遗传学与缺血性卒中后氧化应激的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1171-1177.
[11]	闫然, 闵妍, 全柯华, 李子孝. 脑源性神经营养因子和血清素再摄取转运体编码基因甲基化与卒中预后的关系[J]. 中国卒中杂志, 2022, 17(11): 1178-1182.
[12]	崔凌云, 仇鑫, 周宏宇, 李子孝, 王拥军. DNA甲基化与2型糖尿病的相关性研究进展[J]. 中国卒中杂志, 2022, 17(11): 1183-1188.
[13]	邓宇含, 刘爽, 王子尧, 汪雨欣, 刘宝花. 基于结构化数据和机器学习模型预测普通人群卒中发病风险的系统评价和meta分析 [J]. 中国卒中杂志, 2022, 17(11): 1189-1197.
[14]	刘光亮, 韩凯月, 苏文龙, 张皓. 不同强度有氧踏车训练对不同病程缺血性卒中患者运动和心肺适能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1203-1208.
[15]	孙默一, 张玉梅, 刘然, 赵依双. 不同时间康复介入对卒中患者运动功能的影响 [J]. 中国卒中杂志, 2022, 17(11): 1209-1215.